APPLICATION SITE DESQUAMATION

APPLICATION SITE DESQUAMATION was reported 29 times

APPLICATION SITE DESQUAMATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PERMETHRIN 1 0.0006
1 PYRIDOSTIGMINE BROMIDE 1 0.0001
2 TIMOLOL MALEATE 1 0.0001
3 PEGFILGRASTIM 1 0.0001
4 LOVASTATIN 2 0.0001
5 TESTOSTERONE 1 0.0000
6 ENALAPRIL MALEATE 1 0.0000
7 CONJUGATED ESTROGENS 2 0.0000
8 OXYBUTYNIN 1 0.0000
9 ESTROGENS, CONJUGATED 2 0.0000
10 LORATADINE TABLET 1 0.0000
11 DARBEPOETIN ALFA 1 0.0000
12 ENALAPRIL 1 0.0000
13 AZITHROMYCIN DIHYDRATE 1 0.0000
14 ATENOLOL 2 0.0000
15 DIGOXIN 1 0.0000
16 CISPLATIN 1 0.0000
17 FENTANYL 1 0.0000
18 IBUPFROFEN 2 0.0000
19 IBUPROFEN TABLETS USP, 200MG 2 0.0000
20 IBUPROFEN ORAL 2 0.0000
21 IBUPROFEN CAPSULES 200 MG 2 0.0000
22 LORATADINE 1 0.0000
23 POTASSIUM CHLORIDE 1 0.0000
24 ACYCLOVIR 1 0.0000
25 SERTRALINE HYDROCHLORIDE 1 0.0000
26 MONTELUKAST SODIUM 1 0.0000
27 IBUPROFEN 2 0.0000
28 MYCOPHENOLATE MOFETIL 1 0.0000
29 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 0.0000
30 SPIRONOLACTONE 1 0.0000
31 HYDROCHLOROTHIAZIDE 1 0.0000
32 PANTOPRAZOLE SODIUM 1 0.0000
33 DICLOFENAC SODIUM 1 0.0000
34 ATORVASTATIN CALCIUM 1 0.0000
35 ASPIRIN 2 0.0000
36 METOPROLOL TARTRATE 1 0.0000
37 LEVOTHYROXINE SODIUM 1 0.0000
38 LISINOPRIL 1 0.0000
39 FUROSEMIDE 1 0.0000
40 OMEPRAZOLE MAGNESIUM 1 0.0000
41 PREDNISONE 1 0.0000